Document Detail


Coronary revascularization in end-stage renal disease.
MedLine Citation:
PMID:  17877934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Advanced coronary artery disease and acute cardiac events are the most common causes of death in patients with end-stage renal disease. Because of their heightened risk, end-stage renal disease patients are frequently referred for coronary revascularization. However, these patients are almost always excluded from trials examining various innovations in medical and revascularization interventions for cardiovascular conditions. Extrapolation of trial conclusions regarding dialysis patients can be misleading because the risk-benefit ratios of various interventions in this patient population can be markedly different. Thus, clinical decisions regarding the need for (and type of) coronary revascularization are based on retrospective outcome analyses from various databases. This article reviews the data available in the literature on the morbidity, mortality, and outcomes of dialysis patients undergoing surgical or percutaneous revascularization, particularly with the addition of drug-eluting stents to the available therapeutic options.
Authors:
Khaled M Ziada
Related Documents :
20684824 - Association of monocyte subsets with vulnerability characteristics of coronary plaques ...
10336574 - Impaired cholinergic dilator response of resistance arteries isolated from patients wit...
16504644 - Prognostic significance of st-segment elevation during dobutamine stress echocardiography.
1084134 - Early and late results after surgical treatment of preinfarction angina.
21459934 - Malignancies in italian patients with systemic sclerosis positive for anti-rna polymera...
3412584 - Erectile dysfunction in multiple sclerosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  9     ISSN:  1523-3782     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-19     Completed Date:  2007-10-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  389-95     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536, USA. khaled.ziada@uky.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Clinical Trials as Topic
Coronary Artery Bypass
Coronary Artery Disease / epidemiology*
Coronary Restenosis / prevention & control
Diabetic Angiopathies / therapy
Humans
Kidney Failure, Chronic / epidemiology*,  therapy
Myocardial Revascularization*
Renal Dialysis
Stents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter d...
Next Document:  Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.